Contemporary retinal imaging techniques in diabetic retinopathy: a review

Clinical and Experimental Ophthalmology

Volumn 44, Issue 4, 2016, Pages 289-299

  Cole, Emily Dawn ^a,b   Novais, Eduardo Amorim ^a,c   Louzada, Ricardo Noguera ^a,d   Waheed, Nadia K ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

diabetic macular oedema; diabetic retinopathy; fluorescein angiography; OCT; OCT angiography

Indexed keywords

ADAPTIVE OPTICS; ANGIOGRAPHY; AUTOFLUORESCENCE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FUNDUS AUTOFLUORESCENCE; FUNDUS PHOTOGRAPHY; HUMAN; HYPERSPECTRAL IMAGING; INFRARED REFLECTANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; RETINAL OXIMETRY; REVIEW;

EID: 84974784617     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12711     Document Type: Review

References (83)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414–31.
2. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 2012; 12: 346–54.
3. Abramoff MD, Garvin MK, Sonka M. Retinal imaging and image analysis. IEEE Rev Biomed Eng 2010; 3: 169–208.
4. Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerve - a review. Clin Experiment Ophthalmol 2009; 37: 90–9.
5. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254: 1178–81.
6. Abramoff MD, Garvin MK, Sonka M. Retinal imaging and image analysis. IEEE Rev 2010; 3: 169–208.
7. Danis RP, Hubbard LD. Imaging of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 2011; 11: 236–43.
8. Henricsson M, Karlsson C, Ekholm L, et al. Colour slides or digital photography in diabetes screening—a comparison. Acta Ophthalmol Scand 2000; 78: 164–8.
9. Manjunath V, Papastavrou V, Steel DH, et al. Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening. Eye 2015; 29: 416–23.
10. Liegl R, Liegl K, Ceklic L, et al. Nonmydriatic ultra-wide-field scanning laser ophthalmoscopy (Optomap) versus two-field fundus photography in diabetic retinopathy. Ophthalmologica 2014; 231: 31–6.
11. Panel AAOR. Preferred practice pattern: Diabetic retinopathy. 2003.
12. Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004; 111: 1055–62.
13. Owsley C, McGwin G Jr, Lee DJ, et al. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol 2015; 133: 174–81.
14. Philip S, Fleming AD, Goatman KA, et al. The efficacy of automated “disease/no disease” grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol 2007; 91: 1512–7.
15. Faust O, Acharya UR, Ng EY, Ng KH, Suri JS. Algorithms for the automated detection of diabetic retinopathy using digital fundus images: a review. J Med Syst 2012; 36: 145–57.
16. Brady CJ, Villanti AC, Pearson JL, Kirchner TR, Gupta OP, Shah CP. Rapid grading of fundus photographs for diabetic retinopathy using crowdsourcing. J Med Internet Res 2014; 16: e233.
17. Spaide R. Autofluorescence from the outer retina and subretinal space: hypothesis and review. Retina 2008; 28: 5–35.
18. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina 2008; 28: 385–409.
19. Xu H, Chen M, Manivannan A, Lois N, Forrester JV. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008; 7: 58–68.
20. Pece A, Isola V, Holz F, Milani P, Brancato R. Autofluorescence imaging of cystoid macular edema in diabetic retinopathy. Ophthalmologica 2010; 224: 230–5.
21. McBain VA, Forrester JV, Lois N. Fundus autofluorescence in the diagnosis of cystoid macular oedema. Br J Ophthalmol 2008; 92: 946–9.
22. Hartnett ME, Elsner AE. Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology 1996; 103: 58–71.
23. Remky A, Beausencourt E, Hartnett ME, Trempe CL, Arend O, Elsner AE. Infrared imaging of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1999; 237: 897–901.
24. Remky A, Arend O, Elsner AE, Toonen F, Wolf S, Reim M. Digital imaging of central serous retinopathy using infrared illumination. Ger J Ophthalmol 1995; 4: 203–6.
25. Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res 1996; 36: 191–205.
26. Chung H, Park B, Shin HJ, Kim HC. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema. Ophthalmology 2012; 119: 1056–65.
27. Vujosevic S, Casciano M, Pilotto E, Boccassini B, Varano M, Midena E. Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci 2011; 52: 442–8.
28. Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Experiment Ophthalmol 2006; 34: 33–8.
29. Dmuchowska DA, Krasnicki P, Mariak Z. Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy? Graefes Arch Clin Exp Ophthalmol 2014; 252: 731–8.
30. Wessel MM, Nair N, Aaker GD, Ehrlich JR, D'Amico DJ, Kiss S. Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 2012; 96: 694–8.
31. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98 (5 Suppl): 807–22.
32. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98 (5 Suppl): 834–40.
33. Wang H, Chhablani J, Freeman WR, et al. Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol 2012; 153: 861–7 e1.
34. Diabetic Retinopathy Clinical Research N, Browning DJ, Glassman AR, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007; 114: 525–36.
35. Wessel MM, Aaker GD, Parlitsis G, Cho M, D'Amico DJ, Kiss S. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina 2012; 32: 785–91.
36. Silva PS, Cavallerano JD, Sun JK, Noble J, Aiello LM, Aiello LP. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol 2012; 154: 549–59 e2.
37. Tan CS, Sadda SR, Hariprasad SM. Ultra-widefield retinal imaging in the management of diabetic eye diseases. Ophthal Surg Las Retina 2014; 45: 363–6.
38. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007; 30: 1742–6.
39. Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39: 1569–76.
40. Kawasaki R, Cheung N, Islam FM, et al. Is diabetic retinopathy related to subclinical cardiovascular disease? Ophthalmology 2011; 118: 860–5.
41. Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology 1991; 98: 1139–42.
42. Bearelly S, Rao S, Fekrat S. Anaphylaxis following intravenous fluorescein angiography in a vitreoretinal clinic: report of 4 cases. Can J Ophthalmol 2009; 44: 444–5.
43. Patel RD, Messner LV, Teitelbaum B, Michel KA, Hariprasad SM. Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol 2013; 155: 1038–44 e2.
44. Rabbani H, Allingham MJ, Mettu PS, Cousins SW, Farsiu S. Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema. Invest Ophthalmol Vis Sci 2015; 56: 1482–92.
45. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 113: 325–32.
46. Badaro E, Novais E, Prodocimo LM, Sallum JM. Spectral-domain optical coherence tomography for macular edema. Scientific World Journal 2014; 2014: 191847.
47. Virgili G, Menchini F, Dimastrogiovanni AF, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthalmol Vis Sci 2007; 48: 4963–73.
48. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004; 137: 313–22.
49. Cunha-Vaz J, Coscas G. Diagnosis of macular edema. Ophthalmologica 2010; 224 (Suppl 1): 2–7.
50. Salz DA, Witkin AJ. Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol 2015; 22: 145–50.
51. Sikorski BL, Malukiewicz G, Stafiej J, Lesiewska-Junk H, Raczynska D. The diagnostic function of OCT in diabetic maculopathy. Mediators Inflamm 2013; 2013: 434560.
52. Mathew C, Yunirakasiwi A, Sanjay S. Updates in the management of diabetic macular edema. J Diabetes Res 2015; 2015: 794036.
53. Koleva-Georgieva DN, Sivkova NP. Types of diabetic macular edema assessed by optical coherence tomography. Folia Med (Plovdiv) 2008; 50: 30–8.
54. Koleva-Georgieva DN, Sivkova NP. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy. Folia Med (Plovdiv) 2010; 52: 40–8.
55. Byeon SH, Chu YK, Hong YT, Kim M, Kang HM, Kwon OW. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography. Retina 2012; 32: 1087–99.
56. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118: 615–25.
57. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2010; 117: 2146–51.
58. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119: 789–801.
59. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010; 33: 2399–405.
60. Adhi M, Brewer E, Waheed NK, Duker JS. Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol 2013; 131: 1267–74.
61. Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 2012; 32: 563–8.
62. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 2012; 53: 6017–24.
63. Regatieri CV, Branchini L, Fujimoto JG, Duker JS. Choroidal imaging using spectral-domain optical coherence tomography. Retina 2012; 32: 865–76.
64. Cho H, Alwassia AA, Regiatieri CV, et al. Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography. Retina 2013; 33: 542–7.
65. Ito H, Horii T, Nishijima K, et al. Association between fluorescein leakage and optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Retina 2013; 33: 732–9.
66. Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol 2015; 133: 629–30.
67. Lumbroso B HD, Jia Y, Fujimoto JA, Rispoli M Clinical guide to angio-OCT: Ch. 21 diabetic retinopathy. Jaypee. 2014.
68. de Carlo TE, Romano A, Waheed N, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retina and Vitreous 2015; 1.
69. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol 2015; 160: 35–44 e1.
70. Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina 2015; 35: 2371–6.
71. Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015; 133: 45–50.
72. Hermann B, Fernandez EJ, Unterhuber A, et al. Adaptive-optics ultrahigh-resolution optical coherence tomography. Opt Lett 2004; 29: 2142–4.
73. Roorda A, Romero-Borja F, Donnelly Iii W, Queener H, Hebert T, Campbell M. Adaptive optics scanning laser ophthalmoscopy. Opt Express 2002; 10: 405–12.
74. Huang G, Qi X, Chui TY, Zhong Z, Burns SA. A clinical planning module for adaptive optics SLO imaging. Optom Vis Sci 2012; 89: 593–601.
75. Burns SA, Tumbar R, Elsner AE, Ferguson D, Hammer DX. Large-field-of-view, modular, stabilized, adaptive-optics-based scanning laser ophthalmoscope. J Opt Soc Am A Opt Image Sci Vis 2007; 24: 1313–26.
76. Burns SA, Elsner AE, Chui TY, et al. In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy. Biomed Optic Express 2014; 5: 961–74.
77. Lombardo M, Parravano M, Serrao S, Ducoli P, Stirpe M, Lombardo G. Analysis of retinal capillaries in patients with type 1 diabetes and nonproliferative diabetic retinopathy using adaptive optics imaging. Retina 2013; 33: 1630–9.
78. Johnson WR, Wilson DW, Fink W, Humayun M, Bearman G. Snapshot hyperspectral imaging in ophthalmology. J Biomed Opt 2007; 12: 014036.
79. Harris A, Dinn RB, Kagemann L, Rechtman E. A review of methods for human retinal oximetry. Ophthalmic Surg Lasers Imaging 2003; 34: 152–64.
80. Hardarson SH, Harris A, Karlsson RA, et al. Automatic retinal oximetry. Invest Ophthalmol Vis Sci 2006; 47: 5011–6.
81. Delori FC. Noninvasive technique for oximetry of blood in retinal vessels. Appl Opt 1988; 27: 1113–25.
82. Tiedeman JS, Kirk SE, Srinivas S, Beach JM. Retinal oxygen consumption during hyperglycemia in patients with diabetes without retinopathy. Ophthalmology 1998; 105: 31–6.
83. Yoneya S, Saito T, Nishiyama Y, et al. Retinal oxygen saturation levels in patients with central retinal vein occlusion. Ophthalmology 2002; 109: 1521–6.